[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Alfacalcidol Market Size, Status and Forecast 2020-2026

July 2020 | 99 pages | ID: C4111785A358EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Alfacalcidol is an active metabolite of vitamin D, which performs important functions in regulation of the calcium balance and bone metabolism. Alfacalcidol is a vitamin d-hormone analog that is activated by the enzyme 25-hydroxylase in the liver for systemic and in osteoblasts for local d-hormone actions.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Alfacalcidol market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Alfacalcidol industry.
Based on our recent survey, we have several different scenarios about the Alfacalcidol YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Alfacalcidol will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alfacalcidol market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alfacalcidol market in terms of revenue.
Players, stakeholders, and other participants in the global Alfacalcidol market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Alfacalcidol market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Alfacalcidol market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alfacalcidol market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alfacalcidol market.
The following players are covered in this report:
  • Abcam
  • YaoPharma
  • Kunming Baker Norton Pharmaceutical
  • Teva
  • Leo Pharma
  • Tocris Bioscience
  • LGM Pharma
  • ...
Alfacalcidol Breakdown Data by Type
  • Liquid
  • Capsule
Alfacalcidol Breakdown Data by Application
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alfacalcidol Revenue
1.4 Market Analysis by Type
  1.4.1 Global Alfacalcidol Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Liquid
  1.4.3 Capsule
1.5 Market by Application
  1.5.1 Global Alfacalcidol Market Share by Application: 2020 VS 2026
  1.5.2 Retail Pharmacies
  1.5.3 Hospital Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Alfacalcidol Industry Impact
  1.6.1 How the Covid-19 is Affecting the Alfacalcidol Industry
    1.6.1.1 Alfacalcidol Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Alfacalcidol Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Alfacalcidol Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Alfacalcidol Market Perspective (2015-2026)
2.2 Alfacalcidol Growth Trends by Regions
  2.2.1 Alfacalcidol Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Alfacalcidol Historic Market Share by Regions (2015-2020)
  2.2.3 Alfacalcidol Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Alfacalcidol Market Growth Strategy
  2.3.6 Primary Interviews with Key Alfacalcidol Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Alfacalcidol Players by Market Size
  3.1.1 Global Top Alfacalcidol Players by Revenue (2015-2020)
  3.1.2 Global Alfacalcidol Revenue Market Share by Players (2015-2020)
  3.1.3 Global Alfacalcidol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alfacalcidol Market Concentration Ratio
  3.2.1 Global Alfacalcidol Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Alfacalcidol Revenue in 2019
3.3 Alfacalcidol Key Players Head office and Area Served
3.4 Key Players Alfacalcidol Product Solution and Service
3.5 Date of Enter into Alfacalcidol Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Alfacalcidol Historic Market Size by Type (2015-2020)
4.2 Global Alfacalcidol Forecasted Market Size by Type (2021-2026)

5 ALFACALCIDOL BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Alfacalcidol Market Size by Application (2015-2020)
5.2 Global Alfacalcidol Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Alfacalcidol Market Size (2015-2020)
6.2 Alfacalcidol Key Players in North America (2019-2020)
6.3 North America Alfacalcidol Market Size by Type (2015-2020)
6.4 North America Alfacalcidol Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Alfacalcidol Market Size (2015-2020)
7.2 Alfacalcidol Key Players in Europe (2019-2020)
7.3 Europe Alfacalcidol Market Size by Type (2015-2020)
7.4 Europe Alfacalcidol Market Size by Application (2015-2020)

8 CHINA

8.1 China Alfacalcidol Market Size (2015-2020)
8.2 Alfacalcidol Key Players in China (2019-2020)
8.3 China Alfacalcidol Market Size by Type (2015-2020)
8.4 China Alfacalcidol Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Alfacalcidol Market Size (2015-2020)
9.2 Alfacalcidol Key Players in Japan (2019-2020)
9.3 Japan Alfacalcidol Market Size by Type (2015-2020)
9.4 Japan Alfacalcidol Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Alfacalcidol Market Size (2015-2020)
10.2 Alfacalcidol Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alfacalcidol Market Size by Type (2015-2020)
10.4 Southeast Asia Alfacalcidol Market Size by Application (2015-2020)

11 INDIA

11.1 India Alfacalcidol Market Size (2015-2020)
11.2 Alfacalcidol Key Players in India (2019-2020)
11.3 India Alfacalcidol Market Size by Type (2015-2020)
11.4 India Alfacalcidol Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Alfacalcidol Market Size (2015-2020)
12.2 Alfacalcidol Key Players in Central & South America (2019-2020)
12.3 Central & South America Alfacalcidol Market Size by Type (2015-2020)
12.4 Central & South America Alfacalcidol Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abcam
  13.1.1 Abcam Company Details
  13.1.2 Abcam Business Overview and Its Total Revenue
  13.1.3 Abcam Alfacalcidol Introduction
  13.1.4 Abcam Revenue in Alfacalcidol Business (2015-2020))
  13.1.5 Abcam Recent Development
13.2 YaoPharma
  13.2.1 YaoPharma Company Details
  13.2.2 YaoPharma Business Overview and Its Total Revenue
  13.2.3 YaoPharma Alfacalcidol Introduction
  13.2.4 YaoPharma Revenue in Alfacalcidol Business (2015-2020)
  13.2.5 YaoPharma Recent Development
13.3 Kunming Baker Norton Pharmaceutical
  13.3.1 Kunming Baker Norton Pharmaceutical Company Details
  13.3.2 Kunming Baker Norton Pharmaceutical Business Overview and Its Total Revenue
  13.3.3 Kunming Baker Norton Pharmaceutical Alfacalcidol Introduction
  13.3.4 Kunming Baker Norton Pharmaceutical Revenue in Alfacalcidol Business (2015-2020)
  13.3.5 Kunming Baker Norton Pharmaceutical Recent Development
13.4 Teva
  13.4.1 Teva Company Details
  13.4.2 Teva Business Overview and Its Total Revenue
  13.4.3 Teva Alfacalcidol Introduction
  13.4.4 Teva Revenue in Alfacalcidol Business (2015-2020)
  13.4.5 Teva Recent Development
13.5 Leo Pharma
  13.5.1 Leo Pharma Company Details
  13.5.2 Leo Pharma Business Overview and Its Total Revenue
  13.5.3 Leo Pharma Alfacalcidol Introduction
  13.5.4 Leo Pharma Revenue in Alfacalcidol Business (2015-2020)
  13.5.5 Leo Pharma Recent Development
13.6 Tocris Bioscience
  13.6.1 Tocris Bioscience Company Details
  13.6.2 Tocris Bioscience Business Overview and Its Total Revenue
  13.6.3 Tocris Bioscience Alfacalcidol Introduction
  13.6.4 Tocris Bioscience Revenue in Alfacalcidol Business (2015-2020)
  13.6.5 Tocris Bioscience Recent Development
13.7 LGM Pharma
  13.7.1 LGM Pharma Company Details
  13.7.2 LGM Pharma Business Overview and Its Total Revenue
  13.7.3 LGM Pharma Alfacalcidol Introduction
  13.7.4 LGM Pharma Revenue in Alfacalcidol Business (2015-2020)
  13.7.5 LGM Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Alfacalcidol Key Market Segments
Table 2. Key Players Covered: Ranking by Alfacalcidol Revenue
Table 3. Ranking of Global Top Alfacalcidol Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alfacalcidol Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liquid
Table 6. Key Players of Capsule
Table 7. COVID-19 Impact Global Market: (Four Alfacalcidol Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Alfacalcidol Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Alfacalcidol Players to Combat Covid-19 Impact
Table 12. Global Alfacalcidol Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Alfacalcidol Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Alfacalcidol Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Alfacalcidol Market Share by Regions (2015-2020)
Table 16. Global Alfacalcidol Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Alfacalcidol Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Alfacalcidol Market Growth Strategy
Table 22. Main Points Interviewed from Key Alfacalcidol Players
Table 23. Global Alfacalcidol Revenue by Players (2015-2020) (Million US$)
Table 24. Global Alfacalcidol Market Share by Players (2015-2020)
Table 25. Global Top Alfacalcidol Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alfacalcidol as of 2019)
Table 26. Global Alfacalcidol by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Alfacalcidol Product Solution and Service
Table 29. Date of Enter into Alfacalcidol Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 32. Global Alfacalcidol Market Size Share by Type (2015-2020)
Table 33. Global Alfacalcidol Revenue Market Share by Type (2021-2026)
Table 34. Global Alfacalcidol Market Size Share by Application (2015-2020)
Table 35. Global Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 36. Global Alfacalcidol Market Size Share by Application (2021-2026)
Table 37. North America Key Players Alfacalcidol Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Alfacalcidol Market Share (2019-2020)
Table 39. North America Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 40. North America Alfacalcidol Market Share by Type (2015-2020)
Table 41. North America Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 42. North America Alfacalcidol Market Share by Application (2015-2020)
Table 43. Europe Key Players Alfacalcidol Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Alfacalcidol Market Share (2019-2020)
Table 45. Europe Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Alfacalcidol Market Share by Type (2015-2020)
Table 47. Europe Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Alfacalcidol Market Share by Application (2015-2020)
Table 49. China Key Players Alfacalcidol Revenue (2019-2020) (Million US$)
Table 50. China Key Players Alfacalcidol Market Share (2019-2020)
Table 51. China Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 52. China Alfacalcidol Market Share by Type (2015-2020)
Table 53. China Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 54. China Alfacalcidol Market Share by Application (2015-2020)
Table 55. Japan Key Players Alfacalcidol Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Alfacalcidol Market Share (2019-2020)
Table 57. Japan Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Alfacalcidol Market Share by Type (2015-2020)
Table 59. Japan Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Alfacalcidol Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Alfacalcidol Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Alfacalcidol Market Share (2019-2020)
Table 63. Southeast Asia Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Alfacalcidol Market Share by Type (2015-2020)
Table 65. Southeast Asia Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Alfacalcidol Market Share by Application (2015-2020)
Table 67. India Key Players Alfacalcidol Revenue (2019-2020) (Million US$)
Table 68. India Key Players Alfacalcidol Market Share (2019-2020)
Table 69. India Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 70. India Alfacalcidol Market Share by Type (2015-2020)
Table 71. India Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 72. India Alfacalcidol Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Alfacalcidol Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Alfacalcidol Market Share (2019-2020)
Table 75. Central & South America Alfacalcidol Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Alfacalcidol Market Share by Type (2015-2020)
Table 77. Central & South America Alfacalcidol Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Alfacalcidol Market Share by Application (2015-2020)
Table 79. Abcam Company Details
Table 80. Abcam Business Overview
Table 81. Abcam Product
Table 82. Abcam Revenue in Alfacalcidol Business (2015-2020) (Million US$)
Table 83. Abcam Recent Development
Table 84. YaoPharma Company Details
Table 85. YaoPharma Business Overview
Table 86. YaoPharma Product
Table 87. YaoPharma Revenue in Alfacalcidol Business (2015-2020) (Million US$)
Table 88. YaoPharma Recent Development
Table 89. Kunming Baker Norton Pharmaceutical Company Details
Table 90. Kunming Baker Norton Pharmaceutical Business Overview
Table 91. Kunming Baker Norton Pharmaceutical Product
Table 92. Kunming Baker Norton Pharmaceutical Revenue in Alfacalcidol Business (2015-2020) (Million US$)
Table 93. Kunming Baker Norton Pharmaceutical Recent Development
Table 94. Teva Company Details
Table 95. Teva Business Overview
Table 96. Teva Product
Table 97. Teva Revenue in Alfacalcidol Business (2015-2020) (Million US$)
Table 98. Teva Recent Development
Table 99. Leo Pharma Company Details
Table 100. Leo Pharma Business Overview
Table 101. Leo Pharma Product
Table 102. Leo Pharma Revenue in Alfacalcidol Business (2015-2020) (Million US$)
Table 103. Leo Pharma Recent Development
Table 104. Tocris Bioscience Company Details
Table 105. Tocris Bioscience Business Overview
Table 106. Tocris Bioscience Product
Table 107. Tocris Bioscience Revenue in Alfacalcidol Business (2015-2020) (Million US$)
Table 108. Tocris Bioscience Recent Development
Table 109. LGM Pharma Company Details
Table 110. LGM Pharma Business Overview
Table 111. LGM Pharma Product
Table 112. LGM Pharma Revenue in Alfacalcidol Business (2015-2020) (Million US$)
Table 113. LGM Pharma Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Alfacalcidol Market Share by Type: 2020 VS 2026
Figure 2. Liquid Features
Figure 3. Capsule Features
Figure 4. Global Alfacalcidol Market Share by Application: 2020 VS 2026
Figure 5. Retail Pharmacies Case Studies
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Alfacalcidol Report Years Considered
Figure 9. Global Alfacalcidol Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Alfacalcidol Market Share by Regions: 2020 VS 2026
Figure 11. Global Alfacalcidol Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Alfacalcidol Market Share by Players in 2019
Figure 14. Global Top Alfacalcidol Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alfacalcidol as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Alfacalcidol Revenue in 2019
Figure 16. North America Alfacalcidol Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Alfacalcidol Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Alfacalcidol Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Alfacalcidol Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Alfacalcidol Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Alfacalcidol Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Alfacalcidol Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abcam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abcam Revenue Growth Rate in Alfacalcidol Business (2015-2020)
Figure 25. YaoPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. YaoPharma Revenue Growth Rate in Alfacalcidol Business (2015-2020)
Figure 27. Kunming Baker Norton Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Kunming Baker Norton Pharmaceutical Revenue Growth Rate in Alfacalcidol Business (2015-2020)
Figure 29. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Teva Revenue Growth Rate in Alfacalcidol Business (2015-2020)
Figure 31. Leo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Leo Pharma Revenue Growth Rate in Alfacalcidol Business (2015-2020)
Figure 33. Tocris Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Tocris Bioscience Revenue Growth Rate in Alfacalcidol Business (2015-2020)
Figure 35. LGM Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. LGM Pharma Revenue Growth Rate in Alfacalcidol Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed


More Publications